Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen Posts Strong Q2 Revenue Growth, Increased Income

NEW YORK, July 24 - Invitrogen today reported a surge in second-quarter revenue atop increased R&D spending and net loss.


For the period ended June 30, Invitrogen said total revenue grew to $192.4 million from $164.3 million year over year. The company attributed 7 percent of the growth to "favorable changes in foreign currency exchange rates."


While Invitrogen would not break down dollar figures, the firm said revenue from its cell culture increased 30 percent, while receipts from its molecular-biology products arm increased 10 percent.


Second-quarter R&D spending swelled to $12.6 million from $7.7 million in the same period last year. Despite the increased spending - Invitrogen reported $93.3 million in total operating expenses in the second quarter - net income jumped to $16.9 million, or $.34 per share, from $8 million, or $.15 per share, year over year.


Invitrogen said it had around $541 million cash and cash equivalents as of June 30.


Click here for more information.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.